Navigation Links
Grifols Announces New North American Commercial Operations Organization
Date:8/2/2011

LOS ANGELES, Aug. 2, 2011 /PRNewswire/ -- Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, has announced the structure of its new North American Commercial Operations.  Under the new Commercial Operations structure, the U.S. commercial group will be organized by product portfolio to better serve patients and customers throughout North America.  The Canadian organization, a major presence within North American operations, will remain structurally unchanged.

(Logo: http://photos.prnewswire.com/prnh/20110304/PH59473LOGO)

"By creating cross-functional teams for the major product areas, the sales, marketing, and business functions can work more closely together toward customer-specific goals and objectives," said Gregory Rich, President and CEO of Grifols' North American operations. "This will provide greater focus for our teams and permit us to build upon our existing customer partnerships as well as establish new ones," continued Mr. Rich.  Dedicated national accounts and managed care teams will complement the product portfolio-based sales and marketing teams.  

Joel Abelson will serve as the president of Grifols' North American Commercial Operations.  Mr. Abelson was formerly head of Talecris' International Commercial Operations.  In his new position, he will oversee the marketing and sales strategy for all of Grifols' North American products.  Mr. Abelson has nearly 20 years of senior management experience in the healthcare industry and was responsible for Talecris' commercial operations in all markets outside of the United States and Europe.

Grifols' North American Commercial Operations will be supported by a team of experienced professionals with a proven track record of meeting patient and customer needs in the plasma therapeutics industry and the general healthcare arena.

  • Bill Zabel, Vice President and
    '/>"/>

SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
2. Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations
3. Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
4. Grifols Establishes Expert Advisory Council in Transfusion Medicine
5. Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US
6. Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
7. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
8. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
9. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
10. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
11. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 The Physician-Patient Alliance for Health & ... posted its first blog on July 27, 2011, " Is ... This post featured what happened to ... a grocery store in Goodhue, Minnesota . ... involving 20 others, who took turns pumping his chest. ...
(Date:7/27/2015)... , July 17, 2015 Research and ... of the "G-Protein Coupled Receptors Market: Global ... 2014 - 2022" report to their offering. ... been segmented based on of assay type, therapeutic ... GPCRs market has been categorized into six major ...
(Date:7/27/2015)... VANCOUVER, British Columbia and ...   DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... has accepted subscriptions from institutional and accredited investors ... million shares of common stock and 3.35 million ...
Breaking Medicine Technology:Physician-Patient Alliance for Health & Safety Turns 4 Years Old 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
... China, Jan. 20, 2011 /PRNewswire-Asia/ -- Winner Medical ... Medical") a leading manufacturer of medical dressings, medical ... PurCotton® products in China, today announced that one ... ("Huanggang Cotton"), was recently awarded a Cotton Processing ...
... 2011 BioMed Realty Trust, Inc. (NYSE: ... of its 2010 distributions as follows:Security Description: Common ... ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital ... , $0.140000 , $0.090527 , $0.049473 , $0.000000 ...
Cached Medicine Technology:Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 3BioMed Realty Trust Announces Tax Treatment of 2010 Distributions 2
(Date:7/27/2015)... ... July 28, 2015 , ... ... Skills and Innovative Techniques to Improve the Quality of Investigations , **Presented by ... , Inadequate investigations and CAPAs have been the #1 reason for 483 observations ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk ... regional brain volumes that may be early indicators of Alzheimer’s disease and dementia, ... know that vascular risk factors damage the brain and can result in cognitive ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... its VIP Woman of the Year Circle. She is recognized with this prestigious distinction ... women, boasting more than 700,000 members and over 200 operating Local Chapters. , “I’m ...
(Date:7/27/2015)... , ... July 28, 2015 , ... ... Gilda Baum- Lappe as a 2015 Professional Woman of the Year. Ms. ... largest, most-recognized networking organization of professional women in the country, spanning virtually every ...
(Date:7/27/2015)... ... 27, 2015 , ... The heroin epidemic is affecting the Charlotte in North ... 7th. The rate for heroin usage has continued to climb around the country in ... less expensive alternative for those with an addiction to prescription opiate medications. According to ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Joanne Saniewski, Principal of the Frontier School District's Big Tree Elementary, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3
... cite proprietary research, strategic planning and ... superior creative as keys to their success, INDIANAPOLIS, Jan. ... awards at the Consumer Health World Conference in,Chicago this fall, ... top honors in a national awards program., The Service ...
... Minority and low-income patients are less likely than those ... to post-surgery epidural pain relief, according to new research ... Medicine. The study, published recently in the journal Anesthesia ... may influence health care choices when access to care ...
... Institute for Brain Research will head an ambitious new ... supported by a $8.5M grant from the Ellison Medical ... are prominent experts in neuroimaging and human brain development. ... first appear in early childhood. Autism impairs social interactions ...
... Calif., Jan. 31 BioForm Medical,Inc. (Nasdaq: BFRM ) ... 2007, which is the Company,s second quarter of fiscal,year 2008. ... 31,2007 as compared to $11.8 million for the quarter ended ... net loss was $1.6 million for the,quarter ended December 31, ...
... Inc. (OTC Bulletin Board: ACPH) is pleased to ... Company,s application to,list its common stock on the ... commence trading on NASDAQ on February 4, 2008,under ... to join the growing list of specialty pharmaceutical,companies ...
... D Seniors Also Enjoy Broad Choice of,Prescription Drugs, ... issued the following statement on new budget,figures that report ... over the,next ten years than was estimated last summer:, ... beneficiaries,choice of prescription drugs. New budget documents show that ...
Cached Medicine News:Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 2Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 3Health News:African-Americans less likely to choose epidurals for postoperative pain relief 2Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 3Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 4Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 5Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 6Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 7Health News:Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: